Artal Group S.A. - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 2 filers reported holding ONCOCYTE CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q3 2018$375,000
-2.1%
150,0000.0%0.01%
+25.0%
Q2 2018$383,000
+21.6%
150,0000.0%0.01%
+100.0%
Q1 2018$315,000
-54.9%
150,0000.0%0.00%
-63.6%
Q4 2017$698,000
-38.4%
150,0000.0%0.01%
-45.0%
Q3 2017$1,133,000
+45.3%
150,0000.0%0.02%
+42.9%
Q2 2017$780,000
-12.7%
150,0000.0%0.01%
-30.0%
Q1 2017$893,000
+97.6%
150,000
+134.0%
0.02%
+100.0%
Q4 2016$452,000
+39.9%
64,1020.0%0.01%
+66.7%
Q3 2016$323,000
+41.7%
64,1020.0%0.01%
+20.0%
Q2 2016$228,000
-23.0%
64,1020.0%0.01%
-16.7%
Q1 2016$296,00064,1020.01%
Other shareholders
ONCOCYTE CORP shareholders Q3 2023
NameSharesValueWeighting ↓
AWM Investment Company, Inc. 719,282$2,359,2450.35%
Defender Capital, LLC. 114,520$357,3020.13%
View complete list of ONCOCYTE CORP shareholders